Results 281 to 290 of about 140,654 (327)
Some of the next articles are maybe not open access.
Fcγ Receptor Predictive Genomic Testing and the Treatment of Indolent Non-Hodgkin Lymphoma
Clinical Lymphoma Myeloma and Leukemia, 2010In this month’s edition of Clinical Lymphoma, Myeloma & Leukemia, Zhuang et al provide an insightful review on the affect that polymorphic variants in Fcγ receptors (FcγRs) play in predicting response outcome in patients with non-Hodgkin lymphoma (NHL) who receive rituximab therapy.1 The paper nicely outlines the potential role and limitations of ...
openaire +1 more source
Notes - Some Indole Derivatives Tested for Antitubercular Activity
The Journal of Organic Chemistry, 1956R. Brown, R. Snider, M. Stevenson
openaire +1 more source
Genetics, genomics, and cancer risk assessment
Ca-A Cancer Journal for Clinicians, 2011Kenneth Offit
exaly
Evaluation of the motility indole urease (MIU) test to detect Helicobacter pylori infection.
The Southeast Asian journal of tropical medicine and public health, 2007The aim of this study was to evaluate the diagnostic value of the new motility indole urease (MIU) test and Campylobacter Like Organism (CLO) test with culture as the gold standard. This study were done on 225 biopsy samples from gastric antra taken from chronic dyspeptic patients from several hospitals in Jakarta.
openaire +1 more source
MCED blood test boosts cancer detection in symptomatic patients
Ca-A Cancer Journal for Clinicians, 2023exaly
Multiple Myeloma: Charging Toward a Bright Future
Ca-A Cancer Journal for Clinicians, 2007Parameswaran N Hari
exaly